cureAssess
Assesses whether cure models are appropriate for right-censored survival data, where a fraction of subjects may never experience the event of interest. Implements a two-stage workflow combining Kaplan-Meier visualization and comparison of parametric cure and non-cure models by the Akaike information criterion with formal diagnostics for sufficient follow-up and for the presence of a cured fraction. The diagnostics include the statistics of Maller and Zhou (1992) <doi:10.1093/biomet/79.4.731> and Maller and Zhou (1994) <doi:10.1080/01621459.1994.10476889>, the test of Shen (2000) <doi:10.1016/S0167-7152(00)00063-8>, and the ratio estimation of censored uncured subjects ('RECeUS') method of Selukar and Othus (2023) <doi:10.1002/sim.9610>.
- Estimating the proportion of immunes in a censored sample
- RECeUS: ratio estimation of censored uncured subjects, a different approach for assessing cure model appropriateness in studies with long-term survivors
- Testing for Sufficient Follow-Up and Outliers in Survival Data
- Testing for sufficient follow-up in survival data.
This page was built for software: cureAssess
